From Innovation to Impact: Advancing Melanoma Treatment at Sarah Cannon Research Institute

This virtual symposium is presented by AIM at Melanoma and Sarah Cannon Research Institute.

HCA Healthcare Sarah Cannon Cancer Network unites innovative medical minds and passionate caregivers to advance cancer care globally. Physicians and providers practicing in their network have access to shared expertise and best practices in their pursuit of transforming every phase of cancer care from a patient-centered approach.

Date: Saturday, November 2, 2024
Time: 11:00 AM ET| 10:00 AM CT| 9:00 AM MT| 8:00 AM PT
Format: Presented virtually

Presenters & Topics
10:00 AM CT

Welcome
Meredith McKean MD, MPH
Medical Oncologist
Director, Melanoma and Skin Cancer Research
Sarah Cannon Research Institute

10:10 AM CT

Melanoma Prevention
Meredith McKean MD, MPH
Medical Oncologist
Director, Melanoma and Skin Cancer Research
Sarah Cannon Research

10:40 AM CT

Personalizing Your Melanoma Treatment
Thomas Amatruda, MD
Medical Oncologist
Melanoma Program, Minnesota Oncology
Sarah Cannon Research Institute

11:10 AM CT

Immune and Cellular Therapy 101
Ryan M. Weight DO, MS
Medical Oncologist
Medical Director, The Melanoma and Skin Cancer Institute
Sarah Cannon Research Institute at HealthONE

11:20 AM CT

Break

11:30 AM CT

What Should I Know About Clinical Trials?
Jeff Yorio, MD
Medical Oncologist
Central Texas Site Research Leader, Sarah Cannon Research Institute at Texas Oncology
Chief of Hematology-Oncology, Ascension Seton Medical Center Austin

11:50 AM CT

AIM at Melanoma Patient Resources
Ann Garst Taylor
Director Community Engagement
AIM at Melanoma Foundation

12:00 PM CT

Panel Discussion